RESUMEN
Neurotransmitter-gated ion channels adopt different gating modes to fine-tune signaling at central synapses. At glutamatergic synapses, high and low activity of AMPA receptors (AMPARs) is observed when pore-forming subunits coassemble with or without auxiliary subunits, respectively. Whether a common structural pathway accounts for these different gating modes is unclear. Here, we identify two structural motifs that determine the time course of AMPAR channel activation. A network of electrostatic interactions at the apex of the AMPAR ligand-binding domain (LBD) is essential for gating by pore-forming subunits, whereas a conserved motif on the lower, D2 lobe of the LBD prolongs channel activity when auxiliary subunits are present. Accordingly, channel activity is almost entirely abolished by elimination of the electrostatic network but restored via auxiliary protein interactions at the D2 lobe. In summary, we propose that activation of native AMPAR complexes is coordinated by distinct structural pathways, favored by the association/dissociation of auxiliary subunits.
Asunto(s)
Activación del Canal Iónico/fisiología , Potenciales de la Membrana/fisiología , Mutación/fisiología , Receptores AMPA/química , Receptores AMPA/metabolismo , Sitios de Unión/efectos de los fármacos , Sitios de Unión/genética , Cristalografía por Rayos X , Estimulación Eléctrica , Ácido Glutámico/farmacología , Células HEK293 , Humanos , Activación del Canal Iónico/genética , Litio/farmacología , Potenciales de la Membrana/efectos de los fármacos , Modelos Moleculares , Mutación/genética , Técnicas de Placa-Clamp , Estructura Terciaria de Proteína/genética , Estructura Terciaria de Proteína/fisiología , Subunidades de Proteína/genética , Subunidades de Proteína/metabolismo , Receptores AMPA/genética , Electricidad Estática , TransfecciónRESUMEN
The past fifteen years has seen a revolution in our understanding of ionotropic glutamate receptor (iGluR) structure, starting with the first view of the ligand binding domain (LBD) published in 1998, and in many ways culminating in the publication of the full-length structure of GluA2 in 2009. These reports have revealed not only the central role played by subunit interfaces in iGluR function, but also myriad binding sites within interfaces for endogenous and exogenous factors. Changes in the conformation of inter-subunit interfaces are central to transmission of ligand gating into pore opening (itself a rearrangement of interfaces), and subsequent closure through desensitization. With the exception of the agonist binding site, which is located entirely within individual subunits, almost all modulatory factors affecting iGluRs appear to bind to sites in subunit interfaces. This review seeks to summarize what we currently understand about the diverse roles interfaces play in iGluR function, and to highlight questions for future research.
Asunto(s)
Subunidades de Proteína/fisiología , Receptores Ionotrópicos de Glutamato/fisiología , Animales , Humanos , Activación del Canal Iónico , Preparaciones Farmacéuticas/metabolismo , Estructura Terciaria de Proteína , Subunidades de Proteína/química , Subunidades de Proteína/metabolismo , Receptores Ionotrópicos de Glutamato/química , Receptores Ionotrópicos de Glutamato/metabolismoRESUMEN
Gating of AMPA- and kainate-selective ionotropic glutamate receptors can be defined in terms of ligand affinity, efficacy and the rate and extent of desensitization. Crucial insights into all three elements have come from structural studies of the ligand-binding domain (LBD). In particular, binding-cleft closure is associated with efficacy, whereas dissociation of the dimer formed by neighbouring LBDs is linked with desensitization. We have explored these relationships in the kainate-selective subunit GluK2 by studying the effects of mutating two residues (K531 and R775) that form key contacts within the LBD dimer interface, but whose truncation unexpectedly attenuates desensitization. One mutation (K531A) also switches the relative efficacies of glutamate and kainate. LBD crystal structures incorporating these mutations revealed several conformational changes that together explain their phenotypes. K531 truncation results in new dimer contacts, consistent with slower desensitization and sideways movement in the ligand-binding cleft correlating with efficacy. The tested mutants also disrupted anion binding; no chloride was detected in the dimer-interface site, including in R775A where absence of chloride was the only structural change evident. From this, we propose that the charge balance in the GluK2 LBD dimer interface maintains a degree of instability, necessary for rapid and complete desensitization.
Asunto(s)
Receptores de Ácido Kaínico/química , Receptores de Ácido Kaínico/metabolismo , Animales , Aniones/metabolismo , Sitios de Unión , Cloruros/metabolismo , Cristalografía por Rayos X , Ácido Glutámico , Células HEK293 , Humanos , Ácido Kaínico , Ligandos , Proteínas Mutantes/química , Proteínas Mutantes/metabolismo , Mutación , Fenotipo , Unión Proteica , Multimerización de Proteína , Estructura Terciaria de Proteína , Ratas , Receptores de Ácido Kaínico/genética , Receptor de Ácido Kaínico GluK2RESUMEN
AMPA- and kainate (KA)-selective ionotropic glutamate receptors (iGluRs) respond to agonist by opening (gating), then closing (desensitizing) in quick succession. Gating has been linked to agonist-induced changes within the ligand-binding domain (LBD), and desensitization to rearrangement of a dimer formed by neighboring LBDs. To explore the role of dimer conformation in both gating and desensitization, we compared the conformational effects of two kainate receptor mutants. The first, GluK2-D776K, blocks desensitization of macroscopic current responses ("macroscopic desensitization"). The second, GluK2-M770K, accelerates macroscopic desensitization and eliminates the effects of external ions on channel kinetics. Using structures determined by x-ray crystallography, we found that in both mutants the introduced lysines act as tethered cations, displacing sodium ions from their binding sites within the dimer interface. This results in new inter- and intra-protomer contacts in D776K and M770K respectively, explaining the effects of these mutations on dimer stability and desensitization kinetics. Further, chloride binding was unaffected by the M770K mutation, even though binding of sodium ions has been proposed to promote dimer stability by stabilizing anion binding. This suggests sodium binding may affect receptor function more directly than currently supposed. Notably, we also observed a ligand-specific shift in dimer conformation when comparing LBD dimers in complex with glutamate or the partial agonist KA, revealing a previously unidentified role for dimer orientation in iGluR gating.
Asunto(s)
Activación del Canal Iónico/fisiología , Multimerización de Proteína , Receptores de Glutamato/química , Receptores de Glutamato/fisiología , Receptores de Ácido Kaínico/química , Receptores de Ácido Kaínico/fisiología , Transmisión Sináptica/fisiología , Animales , Cristalografía por Rayos X , Humanos , Ligandos , Unión Proteica/fisiología , Conformación Proteica , Estructura Terciaria de Proteína/fisiología , Ratas , Receptores de Glutamato/metabolismo , Receptores de Ácido Kaínico/metabolismoRESUMEN
Ionotropic glutamate receptor (iGluR) desensitization can be modulated by mutations that change the stability of a dimer formed by the agonist binding domain. Desensitization of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors can be blocked by a single point mutation (e.g., GluR2 L483Y) that stabilizes this dimer in an active conformation. In contrast, desensitization of kainate receptors can be slowed, but not blocked, by similar dimer interface mutations. Only covalent cross-linking via introduced disulfides has been previously shown to block kainate receptor desensitization completely. We have now identified an apparently nondesensitizing GluR6 point mutant (D776K) located at the apex of the ligand binding (S1S2) domain dimer interface. Asp776 is one of a cluster of four charged residues in this region that together mediate direct dimer interactions and contribute to the binding sites for one chloride and two sodium ions. Despite the localized +4 change in the net charge of the S1S2 dimer, the D776K mutation actually increased the thermodynamic stability of the dimer. Unlike GluR6 wild type, the D776K mutant is insensitive to external cations but retains sensitivity to external anions. We therefore hypothesize that the unexpected phenotype of this charge reversal mutation results from the substitution of the sodium ions bound within the dimer interface by the introduced lysine NH(3)(+) groups. The nondesensitizing D776K mutant provides insights into kainate receptor gating and represents a potentially useful new tool for dissecting kainate receptor function.
Asunto(s)
Receptores de Ácido Kaínico/genética , Receptores de Ácido Kaínico/metabolismo , Sustitución de Aminoácidos , Animales , Aniones/metabolismo , Cationes Monovalentes/metabolismo , Cloruros/metabolismo , Humanos , Mutación Puntual , Multimerización de Proteína/genética , Estructura Terciaria de Proteína/genética , Ratas , Sodio/metabolismo , Receptor de Ácido Kaínico GluK2RESUMEN
Kainate receptor responses to domoate are characterized by large steady-state currents and slow deactivation kinetics. To improve our understanding of these responses, we mutated residues at the mouth of the agonist binding pocket of GluR6 using whole-cell electrophysiology to characterize the effects of the mutants. We identified two residues where mutations had significant ligand-specific effects. One, Met691, forms a hydrogen bond that seems to facilitate domoate binding by affecting the main-chain conformation. We found that mutation of Met691 to alanine significantly attenuated responses to domoate but had no effect on responses to glutamate, confirming the importance of this main-chain interaction in GluR6. The second residue, Val685, is located at the mouth of the binding pocket, adjacent to the domoate side-arm. Mutation of Val685 to glutamine increased the rate of decay from steady-state responses to domoate by more than 50-fold but had no effect on the rate or extent of desensitization or on the kinetics of responses to either glutamate or kainate. The V685Q mutant also significantly reduced the potencies of both glutamate (peak) and domoate (peak and steady-state). Empirical analysis using a basic kinetic model indicated that the V685Q phenotype could be fully explained by faster ligand dissociation. The V685Q mutant accelerated receptor deactivation without affecting either desensitization or gating, making it a potentially useful tool for further dissection of ligand binding and gating in kainate receptors.
Asunto(s)
Sustitución de Aminoácidos , Ácido Glutámico/metabolismo , Ácido Kaínico/análogos & derivados , Receptores de Ácido Kaínico/genética , Receptores de Ácido Kaínico/metabolismo , Alanina/metabolismo , Sustitución de Aminoácidos/genética , Animales , Sitios de Unión , Línea Celular , Relación Dosis-Respuesta a Droga , Electrofisiología , Ácido Glutámico/farmacología , Glutamina/metabolismo , Humanos , Enlace de Hidrógeno , Ácido Kaínico/química , Ácido Kaínico/metabolismo , Ácido Kaínico/farmacología , Riñón/citología , Cinética , Modelos Moleculares , Conformación Proteica , Estructura Secundaria de Proteína , Estructura Terciaria de Proteína , Ratas , Receptores AMPA/agonistas , Receptores AMPA/química , Receptores AMPA/metabolismo , Receptores de Ácido Kaínico/agonistas , Receptores de Ácido Kaínico/química , Proteínas Recombinantes/química , Proteínas Recombinantes/metabolismo , Transfección , Receptor de Ácido Kaínico GluK2RESUMEN
Inherited mutations to the tumor suppressor PTEN sporadically lead to cerebellar gangliocytoma characterized by migration defects. This has been modeled by CNS-specific PTEN ablation in mice, but the underlying mechanism cannot be explained by the known role of PTEN in Akt/PKB inactivation. Here we show that the loss of PTEN in mouse cerebellar neurons causes neurodegeneration by hyperphosphorylation of tau and neurofilaments, and activation of Cdk5 and pERK1/2, suggesting that dysregulation of the PTEN/pAkt pathway can mediate neurodegeneration.
Asunto(s)
Cerebelo/metabolismo , Quinasa 5 Dependiente de la Ciclina/metabolismo , Proteína Quinasa 3 Activada por Mitógenos/metabolismo , Proteínas de Neurofilamentos/metabolismo , Fosfohidrolasa PTEN/deficiencia , Proteínas tau/metabolismo , Análisis de Varianza , Animales , Animales Recién Nacidos , Western Blotting , Recuento de Células , Cerebelo/citología , Activación Enzimática/genética , Regulación del Desarrollo de la Expresión Génica/genética , Inmunohistoquímica , Ratones , Ratones Noqueados , Neuronas/metabolismo , FosforilaciónRESUMEN
Ionotropic glutamate receptors from the AMPA and kainate subfamilies share many functional and structural features, but it is unclear whether this similarity extends to the molecular mechanisms underlying receptor desensitization. The current model for desensitization in AMPA receptors involves the rearrangement of dimers formed between subunit agonist binding domains. Key evidence for this has come from a single point mutant (from leucine to tyrosine) that abolished desensitization and that was shown to stabilize the binding domain dimer. However, the desensitization of kainate receptors appears to differ from that of AMPA receptors in several key respects. Although the kinetics of AMPA receptor gating and desensitization are consistent with channels formed from two dimers, similar evidence for the functional involvement of dimers has not been found in kainate receptors. Furthermore, despite the homolog of the nondesensitizing tyrosine in AMPA subunits also being a tyrosine in wild-type kainate subunits, these receptors desensitize rapidly and completely. Using mutagenesis based on the crystal structure of the glutamate receptor subunit GluR6 S1S2 domain in complex with domoate, we identified four residues neighboring this tyrosine that differ between AMPA and kainate subunits and that contribute to the different desensitization kinetics of these receptors. Detailed analysis of the effects of mutations at these sites confirms that there is in fact a common general mechanism for desensitization in non-NMDA receptors, dependent on the stability of the binding domain dimer interface, and reveals the existence of potential agonist-specific desensitization pathways.
Asunto(s)
Receptores AMPA/química , Receptores de Ácido Kaínico/química , Secuencia de Aminoácidos , Sustitución de Aminoácidos , Aminoácidos/química , Animales , Sitios de Unión , Línea Celular , Dimerización , Ácido Glutámico/farmacología , Humanos , Enlace de Hidrógeno , Ácido Kaínico/análogos & derivados , Ácido Kaínico/química , Ácido Kaínico/farmacología , Riñón/citología , Riñón/embriología , Cinética , Modelos Moleculares , Datos de Secuencia Molecular , Mutagénesis Sitio-Dirigida , Técnicas de Placa-Clamp , Mutación Puntual , Unión Proteica , Conformación Proteica , Desnaturalización Proteica , Mapeo de Interacción de Proteínas , Estructura Terciaria de Proteína , Ensayo de Unión Radioligante , Ratas , Receptores AMPA/agonistas , Receptores de Ácido Kaínico/agonistas , Proteínas Recombinantes de Fusión/química , Alineación de Secuencia , Homología de Secuencia de Aminoácido , Transfección , Tirosina/química , Receptor de Ácido Kaínico GluK2RESUMEN
Deregulation of PTEN/Akt signalling has been recently implicated in the pathogenesis of Alzheimer's disease (AD), but the effects on the molecular processes underlying AD pathology have not yet been fully described. Here we report that overexpression of PTEN reduces tau phosphorylation in CHO cells. This effect was abrogated by mutant PTEN constructs with either a catalytically inactive point mutation (C124S) or with only inactive lipid phosphatase activity (G129E), suggesting an indirect, lipid phosphatase-dependent process. The predominant effects of PTEN on tau appeared to be mediated by reducing ERK1/2 activity, but were independent of Akt, GSK-3, JNK and the tau phosphatases PP1 and PP2A. Our studies provide evidence for an effect of PTEN on the phosphorylation of tau in AD pathogenesis, and provide some insight into the mechanisms through which deregulation of PTEN may contribute towards the progression of tauopathy.